Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 293
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
The Problems We Will Be Lucky to Have
Pα+ Psychedelic Bulletin #234: Psychedelics After the Midterms; FDA Answers House Psychedelics Caucus; ICER to Review Compass’ Psilocybin; Terran v. Compass Gets Trial Date
Is It Worth It? What Colorado’s Early Experience With Regulated Psychedelic Care Has the Field Asking, and What To Do About It
Compass Says NDA Will Be Filed Within Two Weeks, Declines to Comment on Usona
Podcast: Usona Files Psilocybin Application, We Review 610 Comments Submitted to FDA, and FDA Approves NRx’s Generic Ketamine
Awakn launches Digital unit and signs agreement with the University of...
Psychedelic Bulletin: CA Decrim. Bill Passes Key Committee; MindMed Publishes MDMA...
COVID-19 and Psychedelic Group Work: It’s Still Too Soon
PTSF54 – Theft, Patents, and Ethical Psychedelic Companies
Former FDA Psychiatry Division Director Dr. Thomas Laughren Joins BetterLife as...
MINDCURE Announces Additional Equity Investment in ATMA, The First Government Approved...
Psychedelic Research Bulletin: March 2021
atai Life Sciences acquires majority stake in Psyber, Inc., to develop...
Silo Pharma Finalizes Sublicense Deal for its Targeted Psilocybin Cancer Therapeutic...
Music is a ‘Hidden Therapist’ in Psilocybin Therapy
Load more
